STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
26.50
-0.22 (-0.82%)
At close: Oct 8, 2025, 4:00 PM EDT
26.85
+0.35 (1.32%)
After-hours: Oct 8, 2025, 5:11 PM EDT
STAAR Surgical Company Employees
STAAR Surgical Company had 1,157 employees as of December 27, 2024. The number of employees increased by 100 or 9.46% compared to the previous year.
Employees
1,157
Change (1Y)
100
Growth (1Y)
9.46%
Revenue / Employee
$193,992
Profits / Employee
-$82,343
Market Cap
1.31B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 27, 2024 | 1,157 | 100 | 9.46% |
| Dec 29, 2023 | 1,057 | 165 | 18.50% |
| Dec 30, 2022 | 892 | 191 | 27.25% |
| Dec 31, 2021 | 701 | 126 | 21.91% |
| Jan 1, 2021 | 575 | 25 | 4.55% |
| Jan 3, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
STAA News
- 6 hours ago - STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card - Business Wire
- 6 hours ago - Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote “AGAINST” Sale to Alcon - Business Wire
- 9 hours ago - Broadwood Partners Questions Integrity of STAAR Surgical's Last-Minute Forecast Change and Fairness Opinion in Sale to Alcon - Business Wire
- 1 day ago - Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon - PRNewsWire
- 2 days ago - Yunqi Capital, One of STAAR Surgical Company's Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon - Business Wire
- 2 days ago - Broadwood Partners Issues Letter to STAAR Surgical's Board Questioning Its Judgment in Proposed Sale to Alcon - Business Wire
- 2 days ago - STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis - Business Wire
- 2 days ago - STAAR Surgical Addresses Broadwood Partners' Flawed, Misleading, and Misinformed Claims - Business Wire